+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell-free DNA Mutation Diagnostics Market - Global Forecast 2026-2032- Product Image
Cell-free DNA Mutation Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Cell-free DNA Mutation Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129125
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell-free DNA Mutation Diagnostics Market is projected to reach USD 4.08 Billion in 2026. It is expected to continue growing at a CAGR of 14.09%, reaching USD 8.98 Billion by 2032.

Introduction to Cell-Free DNA Mutation Diagnostics

Cell-free DNA mutation diagnostics analyze short DNA fragments circulating in body fluids, most commonly blood, to identify genetic alterations without requiring a conventional tissue biopsy. The approach supports minimally invasive testing in oncology and other clinical settings, particularly when tumor tissue is unavailable, difficult to access, or biologically heterogeneous. Its clinical value depends on analytical sensitivity, specimen quality, validated biomarkers, and appropriate interpretation alongside imaging, pathology, and patient history.

Clinical Shifts Reshaping Mutation Detection

The field is moving from single-gene assays toward broader targeted panels and increasingly integrated genomic workflows. Liquid biopsy is being considered across treatment selection, therapy monitoring, resistance assessment, and recurrence surveillance, although each use requires distinct clinical validation. Adoption is also being shaped by pre-analytical standardization, clearer reporting of variants, improvements in assay sensitivity, and the need to distinguish tumor-derived DNA from background cell-free DNA.

Artificial Intelligence Strengthens Interpretation and Workflow Control

Artificial intelligence can support cell-free DNA mutation diagnostics by prioritizing variants, identifying low-frequency signals, improving quality-control review, and combining molecular findings with clinical and imaging information. Machine-learning methods may also help recognize complex mutation patterns and treatment-resistance signatures. Their usefulness remains dependent on representative training data, transparent validation, protection against bias, and human oversight, especially where results influence cancer treatment or other high-consequence decisions.

Regional Insights Across Six Healthcare Environments

North America is characterized by advanced molecular oncology infrastructure, broad clinical research activity, and established pathways for specialized diagnostic testing. Europe combines strong academic capabilities with country-specific reimbursement, regulatory, and data-governance requirements. Asia-Pacific presents substantial variation, ranging from highly developed precision-medicine systems to expanding laboratory capacity and uneven access. Latin America is progressing through reference laboratories, private-sector testing, and selected public initiatives, while affordability and geographic access remain important considerations. The Middle East is developing specialized genomic programs and centralized expertise, with adoption influenced by national health strategies. Africa shows growing interest in precision oncology but continues to face constraints involving laboratory infrastructure, specialist availability, specimen logistics, and equitable access.

Group Insights: Trade, Health, and Security Networks

ASEAN markets are likely to benefit from regional laboratory collaboration, shared training, and referral models that address uneven diagnostic capacity. BRICS members reflect diverse health-system structures, with opportunities for domestic assay development, public research partnerships, and improved access to molecular testing. The European Union emphasizes cross-border evidence, privacy, laboratory quality, and harmonized health-data practices. G7 members generally have mature research and clinical infrastructures, but must still address reimbursement, evidence generation, and equitable implementation. GCC states are investing in advanced healthcare and genomic medicine, making centralized expertise and workforce development important. NATO members may benefit from resilient supply chains, interoperable laboratory standards, and continuity planning for essential diagnostic services.

Country Perspectives on Diagnostic Readiness

Australia combines strong clinical research with geographically dispersed care, making centralized testing and specimen logistics important. Brazil and Mexico face substantial regional variation in access and may benefit from stronger referral networks and public laboratory capacity. Canada and the United States have advanced precision-oncology ecosystems, with ongoing attention to validation, reimbursement, and integration into routine care. China, Japan, and South Korea possess significant molecular research and laboratory capabilities, while implementation is shaped by regulatory pathways and health-system integration. India is expanding genomic testing alongside large and diverse clinical needs, with affordability and quality assurance remaining central. France, Germany, Italy, Spain, and the United Kingdom are advancing liquid-biopsy research and clinical use within distinct national reimbursement and regulatory settings. Russia’s diagnostic development is influenced by domestic infrastructure, access to specialized technologies, and research collaboration conditions.

Actions for Leaders Building Reliable Diagnostic Programs

Industry leaders should prioritize clinically meaningful use cases rather than treating broad mutation detection as an end in itself. They should establish rigorous pre-analytical protocols, proficiency testing, orthogonal confirmation strategies, and transparent reporting standards. Evidence plans should address patient outcomes, not only analytical performance, and should include diverse populations and real-world implementation settings. Partnerships with hospitals, pathology laboratories, researchers, and regulators can accelerate validation while clarifying reimbursement requirements. Organizations should also invest in secure data governance, explainable artificial-intelligence tools, workforce training, and resilient supply chains to support dependable deployment.

Research Methodology for Evidence-Based Assessment

This executive summary uses a structured review of the cell-free DNA mutation diagnostics domain, organizing findings around technology development, clinical applications, artificial-intelligence effects, geography, and healthcare-system context. Evidence should be assessed using peer-reviewed research, regulatory documentation, clinical guidelines, laboratory standards, and publicly available health-system information. Analytical performance, specimen handling, clinical validity, clinical utility, implementation barriers, and governance considerations should be evaluated separately. Geographic comparisons should account for differences in infrastructure, regulation, reimbursement, population needs, and access rather than assuming uniform adoption conditions.

Conclusion: Translating Liquid Biopsy Capability into Clinical Value

Cell-free DNA mutation diagnostics offer a less invasive route to molecular information and can complement tissue-based testing across selected clinical decisions. Sustainable progress will depend less on technical breadth alone than on reproducible specimen handling, clinically validated interpretation, equitable access, and integration into care pathways. Regional and country differences require adaptable implementation models, while artificial intelligence should be deployed with strong validation and human governance. Leaders that connect analytical rigor with clinical utility and responsible data practices will be best positioned to advance the field.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell-free DNA Mutation Diagnostics Market, by Technology
7.1. Introduction
7.2. Digital PCR
7.2.1. BEAMing
7.2.2. Droplet Digital PCR
7.3. NGS
7.3.1. Targeted Sequencing
7.3.2. Whole Exome Sequencing
7.3.3. Whole Genome Sequencing
7.4. qPCR
7.4.1. High-Resolution Melt
7.4.2. Real-Time PCR
8. Cell-free DNA Mutation Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. PCR Instruments
8.2.2. Sequencers
8.3. Reagents
8.3.1. Library Prep Kits
8.3.2. PCR Reagents
8.3.3. Sequencing Kits
8.4. Software & Services
8.4.1. Consulting
8.4.2. Data Analysis Software
8.4.3. Sequencing Services
9. Cell-free DNA Mutation Diagnostics Market, by Workflow Stage
9.1. Introduction
9.2. Data Analysis
9.2.1. Bioinformatics
9.2.2. Cloud Analysis
9.3. Library Preparation
9.3.1. DNA Extraction
9.3.2. Library Construction
9.4. Reporting
9.4.1. Clinical Reporting
9.4.2. Research Reporting
9.5. Sample Collection
9.6. Sequencing
9.6.1. Instrument Run
9.6.2. Quality Control
10. Cell-free DNA Mutation Diagnostics Market, by Application
10.1. Introduction
10.2. Infectious Disease
10.2.1. Bacterial Identification
10.2.2. Viral Detection
10.3. Oncology
10.3.1. Liquid Biopsy
10.3.2. Minimal Residual Disease
10.3.3. Solid Tumor Profiling
10.4. Prenatal Testing
10.4.1. Aneuploidy Screening
10.4.2. Non-Invasive Prenatal Testing
10.5. Transplantation Monitoring
11. Cell-free DNA Mutation Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Centers
11.3. Contract Research Organizations
11.4. Hospitals And Diagnostic Laboratories
11.5. Reference Laboratories
11.6. Research Institutes
12. Cell-free DNA Mutation Diagnostics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Cell-free DNA Mutation Diagnostics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Cell-free DNA Mutation Diagnostics Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Adaptive Biotechnologies Corporation
16.3. BGI Genomics Co., Ltd.
16.4. BillionToOne, Inc.
16.5. Biocept, Inc.
16.6. Biodesix, Inc.
16.7. Bio-Rad Laboratories, Inc.
16.8. CareDx, Inc.
16.9. Exact Sciences Corporation
16.10. F. Hoffmann-La Roche Ltd
16.11. Foundation Medicine, Inc.
16.12. GRAIL, Inc.
16.13. Guardant Health, Inc.
16.14. Illumina, Inc.
16.15. Invitae Corporation
16.16. Laboratory Corporation of America Holdings
16.17. Myriad Genetics, Inc.
16.18. Natera, Inc.
16.19. NeoGenomics Laboratories, Inc.
16.20. QIAGEN N.V.
16.21. Quest Diagnostics Incorporated
16.22. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cell-free DNA Mutation Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Cell-free DNA Mutation Diagnostics Market, Research Design
FIGURE 3. Global Cell-free DNA Mutation Diagnostics Market, Research Framework
FIGURE 4. Global Cell-free DNA Mutation Diagnostics Market, Data Triangulation
FIGURE 5. Global Cell-free DNA Mutation Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cell-free DNA Mutation Diagnostics Market Size, by Product, 2025 vs 2032 (%)
FIGURE 9. Global Cell-free DNA Mutation Diagnostics Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2025 vs 2032 (%)
FIGURE 11. Global Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cell-free DNA Mutation Diagnostics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Cell-free DNA Mutation Diagnostics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cell-free DNA Mutation Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Cell-free DNA Mutation Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cell-free DNA Mutation Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Cell-free DNA Mutation Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cell-free DNA Mutation Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cell-free DNA Mutation Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Cell-free DNA Mutation Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cell-free DNA Mutation Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cell-free DNA Mutation Diagnostics Market Segmentation & Coverage
TABLE 2. Global Cell-free DNA Mutation Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global BEAMing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global BEAMing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global BEAMing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Droplet Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Droplet Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Droplet Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global NGS Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global NGS Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global NGS Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global qPCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global qPCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global qPCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global High-Resolution Melt Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global High-Resolution Melt Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global High-Resolution Melt Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Real-Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Real-Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Real-Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 35. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global PCR Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global PCR Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global PCR Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Library Prep Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Library Prep Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Library Prep Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Consulting Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Consulting Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Consulting Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Sequencing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 69. Global Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Bioinformatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Bioinformatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Bioinformatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Cloud Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Cloud Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Cloud Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Library Preparation Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Library Preparation Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Library Preparation Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global DNA Extraction Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global DNA Extraction Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global DNA Extraction Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Library Construction Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Library Construction Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Library Construction Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Clinical Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Clinical Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Clinical Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Research Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Research Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Research Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Sample Collection Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Sample Collection Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Sample Collection Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Instrument Run Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Instrument Run Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Instrument Run Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Bacterial Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Bacterial Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Bacterial Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Viral Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Viral Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Viral Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Minimal Residual Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Minimal Residual Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Minimal Residual Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Solid Tumor Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Solid Tumor Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Solid Tumor Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Aneuploidy Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Aneuploidy Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Aneuploidy Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Non-Invasive Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Non-Invasive Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Non-Invasive Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Transplantation Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Transplantation Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Transplantation Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Global Academic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Academic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Academic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Hospitals And Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Hospitals And Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Hospitals And Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. North America Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. North America Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. North America Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 181. North America Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 182. North America Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 183. North America Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 184. North America Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 185. North America Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 186. North America Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 187. North America Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 188. North America Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 189. North America Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 190. North America Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 191. North America Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 192. North America Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. North America Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 194. North America Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 195. North America Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 196. North America Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 200. Latin America Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 201. Latin America Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 202. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 203. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 204. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 205. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 206. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 207. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 208. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 209. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 210. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 211. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 213. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 214. Latin America Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 215. Latin America Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Europe Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Europe Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. Europe Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 219. Europe Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 220. Europe Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 221. Europe Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 222. Europe Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 223. Europe Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 224. Europe Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 225. Europe Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 226. Europe Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 227. Europe Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 228. Europe Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 229. Europe Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 230. Europe Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. Europe Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 232. Europe Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 233. Europe Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 234. Europe Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 236. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 238. Middle East Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 239. Middle East Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 240. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 242. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 243. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 244. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 245. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 246. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 247. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 248. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 249. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 251. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 252. Middle East Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 253. Middle East Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Africa Cell-free DNA Mutation Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. Africa Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Africa Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 257. Africa Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 258. Africa Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 259. Africa Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 260. Africa Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 261. Africa Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 262. Africa Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 263. Africa Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 264. Africa Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 265. Africa Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 266. Africa Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 267. Africa Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 268. Africa Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Africa Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 270. Africa Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 271. Africa Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 272. Africa Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Global Cell-free DNA Mutation Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 277. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 278. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 279. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 280. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 281. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 282. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 283. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 284. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 285. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 286. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 287. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 288. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 290. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 291. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 292. ASEAN Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. GCC Cell-free DNA Mutation Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. GCC Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 295. GCC Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 296. GCC Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 297. GCC Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 298. GCC Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 299. GCC Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 300. GCC Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 301. GCC Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 302. GCC Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 303. GCC Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 304. GCC Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 305. GCC Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 306. GCC Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 307. GCC Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. GCC Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 309. GCC Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 310. GCC Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 311. GCC Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. European Union Cell-free DNA Mutation Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 313. European Union Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 314. European Union Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 315. European Union Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 316. European Union Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 317. European Union Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 318. European Union Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 319. European Union Cell-free DNA Mutation Diagnostics Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 320. European Union Cell-free DNA Mutation Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 321. European Union Cell-free DNA Mutation Diagnostics Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 322. European Union Cell-free DNA Mutation Diagnostics Market Size, by Data Analysis, 2017-2032 (USD Million)
TABLE 323. European Union Cell-free DNA Mutation Diagnostics Market Size, by Library Preparation, 2017-2032 (USD Million)
TABLE 324. European Union Cell-free DNA Mutation Diagnostics Market Size, by Reporting, 2017-2032 (USD Million)
TABLE 325. European Union Cell-free DNA Mutation Diagnostics Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 326. European Union Cell-free DNA Mutation Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. European Union Cell-free DNA Mutation Diagnostics Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 328. European Union Cell-free DNA Mutation Diagnostics Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 329. European Union Cell-free DNA Mutation Diagnostics Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 330. European Union Cell-free DNA Mutation Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 332. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 333. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 334. BRICS Cell-free DNA Mutation Diagnostics Market Size, by NGS, 2017-2032 (USD Million)
TABLE 335. BRICS Cell-free DNA Mutation Diagnostics Market Size, by qPCR, 2017-2032 (USD Million)
TABLE 336. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 337. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 338. BRICS Cell-free DNA Mutation Diagnostics Market Size, by Reagents,

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • BGI Genomics Co., Ltd.
  • BillionToOne, Inc.
  • Biocept, Inc.
  • Biodesix, Inc.
  • Bio‑Rad Laboratories, Inc.
  • CareDx, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Foundation Medicine, Inc.
  • GRAIL, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics Laboratories, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Cell Free DNA (cfDNA) Testing Market Report 2026 - Product Image

Cell Free DNA (cfDNA) Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cell-Free DNA Testing Market - Global Forecast 2026-2032 - Product Image

Cell-Free DNA Testing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Cell Free Dna (Cfdna) Testing Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cell Free Dna (Cfdna) Testing Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Cell-Free DNA Collection Tube Market - Global Forecast 2026-2032 - Product Image

Cell-Free DNA Collection Tube Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cell-Free DNA (cfDNA) Kits Market Report 2026 - Product Image

Cell-Free DNA (cfDNA) Kits Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.